The phrase "approach may need" is correct and usable in written English.
It can be used when discussing a method or strategy that requires adjustments or improvements.
Example: "The current approach may need some modifications to better address the challenges we are facing."
Alternatives: "method might require" or "strategy could need".
That approach may need to be reviewed as violent protesters target officers and landmark buildings, such as during the student protests in central London on November 10, he said.
However, the possibility that the intramedullary approach may need to be converted to a transfemoral approach should be anticipated.
In clinical practice, the approach may need to be individualized to the problems experienced by the patient.
In the era of targeted therapies, however, this approach may need to change, in a number of ways.
The BML segmentation approach may need to be reevaluated when deployed in new data sets using different MR scanners, MR sequences, or study populations (e.g., knees without full thickness cartilage loss).
Our study indicates that CMD and associated suicidal behaviour are common and need to be considered in the provision of care although the approach may need to include interventions at the population level to address population level determinants.
"And we cannot exclude that different approaches may need to be implemented for the first years following the expiry of the current regulation while laying the groundwork for more sustainable long-term solutions.
For rare species, sampling using point count approaches is unlikely to provide sufficient precision, and alternative sampling approaches may need to be employed.
With the popularity of new networking technologies such as software-defined network (SDN) and cloud computing, current mobility management protocols and approaches may need to be reevaluated and redefined due to various new issues such as location update, signaling overhead, handover latency, security, and privacy.
Therefore, other therapeutic approaches may need to be developed to selectively deplete Foxp3+ cells in advanced K-Ras driven lung cancers.
In the mean time, affinity maturation by CDR-shuffling using phage display approaches may need to be adopted if further affinity improvement of h357 IgG is required for therapeutic use.
